Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.
作者信息
Borst G C
出版信息
J Ky Med Assoc. 1988 Mar;86(3):129-30.
PMID:3356924
Abstract
摘要
相似文献
1
Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.
J Ky Med Assoc. 1988 Mar;86(3):129-30.
2
Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.
Age Ageing. 1997 Sep;26(5):409-10.
3
[Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].奥曲肽在磺脲类药物所致低血糖治疗中的作用
Rev Med Suisse. 2008 Aug 20;4(167):1764-7.
4
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.严重的磺酰脲类药物引起的低血糖：老年患者处方不谨慎和糖尿病护理不足的问题。
Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777.
5
Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.格列吡嗪，一种治疗糖尿病的新型磺脲类药物。1064例临床经验总结。
Arzneimittelforschung. 1972 Nov;22(11):1881-5.
6
[Modern treatment of diabetes mellitus with sulfonylurea compounds].
Z Arztl Fortbild (Jena). 1979 May 15;73(10):482-7.
7
Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.奥曲肽与标准疗法联合应用与单独使用标准疗法治疗磺脲类药物所致低血糖的比较。
Ann Emerg Med. 2008 Jun;51(6):795-6; author reply 796-7. doi: 10.1016/j.annemergmed.2007.11.043.
8
The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.KCNJ11基因的E23K变体与2型糖尿病患者严重磺脲类药物诱导的低血糖风险
Horm Metab Res. 2009 May;41(5):387-90. doi: 10.1055/s-0029-1192019. Epub 2009 Feb 12.
9
Long-acting sulfonylureas -- long-acting hypoglycaemia.长效磺脲类药物——长效低血糖症。
Med J Aust. 2004 Jan 19;180(2):84-5.
10
[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
Schweiz Med Wochenschr. 1986 Feb 1;116(5):145-51.
Zotero 插件